The outlook of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial surge generated substantial returns , generic copies have significantly impacted sales . Investing in connected pharmaceutical companies now requires a careful assessment of intellectual property protection , evolving patient changes, and